Represented AzurRx BioPharma, Inc., a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, in its initial public offering and NASDAQ listing.
){kind=logo}
It looks like we may have content for your preferred language. Would you like to view this page in English?
